Amazon India unveils Marketplace Appstore to offer business solutions

The platform would allow sellers to search for applications that help them automate, grow and manage their business as well as connect developers with retailers. E-commerce giant, Amazon.com, Inc. has recently unveiled The Amazon Mark....

SSE in discussion with Ovo to sell its energy business in UK

SSE has also been fined £700,000 by Ofgem due to its inability to meet target smart gas meter installation in the previous year.   SSE announced that it would float or sell its arm of energy services after the first half of 2....

Kohlberg & Co. to merge Bemis® Healthcare Packaging with Nelipak

Bemis® will be incorporated with Nelipak and jointly operate under the Nelipak® Healthcare Packaging brand. Nelipak® Corporation, Inc., a company that focuses on providing custom packaging for pharmaceutical and medical industr....

Lenovo launches new ThinkSystem SR635 & SR655 single-socket servers

The new servers will offer businesses with performance of a dual-socket server at the price of a single-socket. Chinese multinational conglomerate, Lenovo has recently revealed its new ThinkSystem SR655 and SR635 server platforms, two of ....

Novartis backs Zolgensma® to treat spinal muscular atrophy in children

Zolgensma is specifically designed to be given to children below the age of two years with SMA.   The FDA acknowledged that there were data integrity issues with Zolgensma’s Biologics License Application. The U.S. Food and ....

Alkahest reveals positive outcomes from Phase 2 study of GRF6019

The study cites that dosing with GRF6019 were harmless and well-tolerated in patients with Alzheimer’s disease dementia (AD). Alkahest, Inc., a clinical-stage biopharmaceutical company focused on researching and creating transformati....

Precigen Inc. doses first patient in study of advanced cancer therapy

PRGN-3005 UltraCAR-T is a type of multigenic CAR-T cell therapy which utilizes Precigens advanced non-viral gene delivery system Precigen Inc, a biopharmaceutical company and a wholly owned subsidiary of Intrexon Corporation, has recently ....

Risuteganib enhances visual acuity in patients with age-related dAMD

· Patients enrolled to the clinical trial were given 1.0 mg of sham injection or risuteganib. · It would not be a helpful treatment for all patients with dry macular degeneration. Results from a Phase 2 clinical trial, which....

I-Mab, TRACON Pharmaceuticals begins human trial of CD73 antibody TJD5

The study will evaluate the tolerability and safety of TJD5 and determine recommended doses for future clinical studies. I-Mab Biopharma (I-Mab), a clinical stage biopharmaceutical firm focused on the discovery and development of biologics....

SELLAS doses first patient in study of GPS and KEYTRUDA® combination

The trial involves patients diagnosed with acute myeloid leukemia and colorectal, ovarian, triple negative breast and small cell lung cancers. SELLAS Life Sciences Group, Inc., a biopharmaceutical company focusing on the development of ca....